Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 2 (2005), Issue 9 (September)

1. Overview of recruitment for the osteoporotic fractures in men study (MrOS).
   Contemp Clin Trials, 26(5): 557-68. [Abstract] [Full-text]
2. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.
   Contemp Clin Trials, 26(5): 569-85. [Abstract] [Full-text]
3. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.
   Maturitas, 52(1): 70-7. [Abstract] [Full-text]
4. Poor nutrition in prepubertal Japanese children at the end of World War II suppressed bone development.
   Maturitas, 52(1): 32-4. [Abstract] [Full-text]
5. Race and sex differences and contribution of height: a study on bone size in healthy Caucasians and Chinese.
   Am J Hum Biol, 17(5): 568-75. [Abstract] [Full-text]
6. Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss.
   J Clin Endocrinol Metab, 90(9): 5127-33. [Abstract] [Full-text]
7. A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis.
   J Clin Endocrinol Metab, 90(9): 5386-92. [Abstract] [Full-text]
8. Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study.
   J Clin Endocrinol Metab, 90(9): 5018-24. [Abstract] [Full-text]
9. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
   J Clin Endocrinol Metab, 90(9): 5031-6. [Abstract] [Full-text]
10. Depression in anorexia nervosa: a risk factor for osteoporosis.
    J Clin Endocrinol Metab, 90(9): 5382-5. [Abstract] [Full-text]
11. Biomechanical evaluation of kyphoplasty with calcium sulfate cement in a cadaveric osteoporotic vertebral compression fracture model.
    Spine J, 5(5): 489-93. [Abstract] [Full-text]
12. Telomere length versus hormonal and bone mineral status in healthy elderly men.
    Mech Ageing Dev, 126(10): 1115-22. [Abstract] [Full-text]
13. Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis.
    Eur J Obstet Gynecol Reprod Biol, 122(1): 73-8. [Abstract] [Full-text]
14. Healing of fractures in osteoporotic rat mandible shown by the expression of bone morphogenetic protein-2 and tumour necrosis factor-alpha.
    Br J Oral Maxillofac Surg, 43(5): 383-91. [Abstract] [Full-text]
15. Genetic liability to fractures in the elderly.
    Arch Intern Med, 165(16): 1825-30. [Abstract] [Full-text]
16. The relation between dietary protein, calcium and bone health in women: results from the EPIC-Potsdam cohort.
    Ann Nutr Metab, 49(5): 312-8. [Abstract] [Full-text]
17. Relationships between muscle strength and bone mineral density of three body regions in sedentary postmenopausal women.
    Rheumatol Int, 25(7): 513-7. [Abstract] [Full-text]
18. Osteoporosis at presentation of childhood ALL: management with pamidronate.
    Pediatr Hematol Oncol, 22(7): 543-50. [Abstract] [Full-text]
19. The effectiveness of an osteoporosis prevention education programme for women in Hong Kong: a randomized controlled trial.
    J Clin Nurs, 14(9): 1112-23. [Abstract] [Full-text]
20. The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1.
    Acta Obstet Gynecol Scand, 84(10): 987-91. [Abstract] [Full-text]
21. Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis.
    Bone, 37(4): 433-40. [Abstract] [Full-text]
22. Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromsø study: a population-based study.
    Am J Epidemiol, 162(7): 633-43. [Abstract] [Full-text]
23. Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats.
    J Med Food, 8(3): 369-76. [Abstract] [Full-text]
24. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
    Cancer, 104(7): 1520-30. [Abstract] [Full-text]
25. Position of the American Dietetic Association: the impact of fluoride on health.
    J Am Diet Assoc, 105(10): 1620-8. [Abstract] [Full-text]
26. Ethnic differences in the frequency and circumstances of falling in older community-dwelling women.
    J Am Geriatr Soc, 53(10): 1774-9. [Abstract] [Full-text]
27. The beneficial effects of group-based exercises on fall risk profile and physical activity persist 1 year postintervention in older women with low bone mass: follow-up after withdrawal of exercise.
    J Am Geriatr Soc, 53(10): 1767-73. [Abstract] [Full-text]
28. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    J Am Geriatr Soc, 53(10): 1697-704. [Abstract] [Full-text]
29. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.
    Proc Natl Acad Sci U S A, 102(39): 14022-7. [Abstract] [Full-text]
30. Inclusion of tobacco exposure as a predictive factor for decreased bone mineral content.
    Nicotine Tob Res, 7(5): 719-24. [Abstract] [Full-text]
31. Contribution of muscular weakness to osteoporosis: computational and animal models.
    Clin Biomech (Bristol, Avon), 20(9): 984-97. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.